SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-24-027568
Filing Date
2024-03-29
Accepted
2024-03-28 21:47:19
Documents
14
Period of Report
2024-03-26
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0202871-8ka1_gamida.htm   iXBRL 8-K/A 43567
2 ENGLISH TRANSLATION OF CERTAIN FILINGS IN THE RESTRUCTURING PROCEEDING ea020287101ex99-1_gamida.htm EX-99.1 330984
  Complete submission text file 0001213900-24-027568.txt   606524

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE gmda-20240326.xsd EX-101.SCH 3024
4 XBRL LABEL FILE gmda-20240326_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE gmda-20240326_pre.xml EX-101.PRE 22365
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0202871-8ka1_gamida_htm.xml XML 4528
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Filer) CIK: 0001600847 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38716 | Film No.: 24801804
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)